Natera's Signatera Wins First MRD Approval in Japan for Colorectal Cancer
From the article
The PMDA cleared the tumor-informed liquid biopsy test for use in the adjuvant setting; Natera plans to get approval for muscle-invasive bladder cancer next.
Continue reading on iongenomics.bioYou might also wanna read
Medicinal plants used to treat infectious diseases in French Polynesia: an ethnobotanical survey and antibacterial evaluation
archimer.ifremer.fr·just now
A standardized method to monitor marine litter in submarine canyons: implementation in Atlantic and Mediterranean reef ecosystems
archimer.ifremer.fr·just now
Women in Nonequilibrium Statistical Physics, 7–11 Sep 2026 at KU Leuven (Belgium).
fys.kuleuven.be·just now
Oceanographic parameters associated with spatial occurrence of cephalopods in standardized demersal fishing trawls in the NE Atlantic
archimer.ifremer.fr·just now
BPI Asia Digital Series
bioprocessintl.com·just now
Offshore wind port operator make fresh changes to plans to reduce wetlands impact, noise
Renew Economy·23m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.